Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

HYPR

Hyperfine Inc

Sep 06 • 04:00PM ET

0.9000

Dollar change -0.0108
Percentage change -1.19	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

Held by: VTI VXF

Index	-	P/E	-	EPS (ttm)	-0.58	Insider Own	27.57%	Shs Outstand	56.84M	Perf Week	-7.53%
Market Cap	65.36M	Forward P/E	-	EPS next Y	-0.55	Insider Trans	-0.03%	Shs Float	52.60M	Perf Month	-19.64%
Income	-41.45M	PEG	-	EPS next Q	-0.14	Inst Own	11.31%	Short Float	2.80%	Perf Quarter	1.12%
Sales	11.94M	P/S	5.47	EPS this Y	8.60%	Inst Trans	-5.12%	Short Ratio	9.38	Perf Half Y	-25.00%
Book/sh	0.92	P/B	0.97	EPS next Y	2.94%	ROA	-43.81%	Short Interest	1.47M	Perf Year	-55.88%
Cash/sh	0.74	P/C	1.21	EPS next 5Y	-	ROE	-48.74%	52W Range	0.76 - 2.15	Perf YTD	-19.64%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-62.08%	52W High	-58.14%	Beta	0.84
Dividend TTM	-	Quick Ratio	7.24	Sales past 5Y	275.41%	Gross Margin	44.51%	52W Low	18.22%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	8.08	EPS Y/Y TTM	16.63%	Oper. Margin	-375.85%	RSI (14)	33.69	Volatility	7.92% 7.48%
Employees	131	Debt/Eq	0.00	Sales Y/Y TTM	22.01%	Profit Margin	-347.05%	Recom	2.33	Target Price	1.23
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	5.62%	Payout	-	Rel Volume	0.69	Prev Close	0.91
Sales Surprise	11.27%	EPS Surprise	0.00%	Sales Q/Q	7.39%	Earnings	Aug 08 AMC	Avg Volume	156.83K	Price	0.90
SMA20	-13.85%	SMA50	-15.92%	SMA200	-12.45%	Trades		Volume	108,780	Change	-1.19%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-11-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$8 → $2.40
May-31-22	Initiated	Evercore ISI	Outperform	$7
Apr-14-22	Initiated	Wells Fargo	Overweight	$8

Aug-28-24 04:05PM	Hyperfine, Inc. to Participate in Upcoming Investor Conferences (Business Wire) -7.30%
Aug-08-24 09:58PM	HYPR Stock Earnings: Hyperfine Meets EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:05PM	Hyperfine, Inc. Reports Record Quarterly Revenue and Raises FY 2024 Revenue Guidance (GlobeNewswire)
Jul-30-24 09:00AM	Hyperfine Announces Presentation of Initial Data from Observational Clinical Studies Evaluating the Use of Portable MR Brain Imaging for Alzheimer's Patients (Business Wire)
Jul-17-24 09:00AM	Hyperfine Announces FDA Clearance of Software Update That Enables Faster Acquisition of Best-in-Class Ultra-Low-Field Brain Images (Business Wire)
09:23AM	Loading…
Jul-16-24 09:23AM	Hyperfine (HYPR) to Release ACTION PMR Study Data for Swoop (Zacks) +13.21%
Jul-15-24 09:00AM	Portable MRI as a Tissue Clock for Acute Ischemic Stroke: Multi-Site Study to be Published in August 2024 Edition of Annals of Neurology Shows the Value of the Ultra-Low-Field Swoop Portable MR Imaging System in Acute Stroke Diagnosis (Business Wire)
Jul-11-24 04:05PM	Hyperfine, Inc. to Announce Second Quarter 2024 Financial Results on August 8, 2024 (Business Wire)
09:14AM	Hyperfine (HYPR) Inks New Partnerships to Expand in Europe (Zacks)
Jul-10-24 09:00AM	Hyperfine Expands European Market Reach with Additional Strategic Distributor Partners (Business Wire) +8.07%
Jun-25-24 09:00AM	Clinical Research Using Swoop System for Alzheimer's Disease Monitoring to be Presented at the 2024 Alzheimers Association International Conference (Business Wire)
Jun-03-24 04:05PM	Hyperfine, Inc. to Host Analyst and Investor Education Webcast with Clinical and Brain Imaging Experts on June 25, 2024 (Business Wire)
May-28-24 09:00AM	Hyperfine, Inc. Continues Global Market Expansion by Entering Into a Distribution Partnership with Radiosurgery Global, Ltd. to Bring the Swoop System to India (Business Wire)
May-24-24 06:00AM	The Dollar Menu Portfolio: 7 Penny Stocks to Buy With Spare Change (InvestorPlace)
May-22-24 04:05PM	Hyperfine, Inc. to Present at the Jefferies Global Healthcare Conference (Business Wire) -5.38%
09:00AM	Loading…
09:00AM	Hyperfine, Inc. Celebrates ASNR 2024 (Business Wire)
May-14-24 03:04AM	Hyperfine Inc (HYPR) Q1 2024 Earnings Call Transcript Highlights: Navigating Growth and Challenges (GuruFocus.com) +10.14%
May-13-24 08:53PM	HYPR Stock Earnings: Hyperfine Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:15PM	Hyperfine, Inc. (HYPR) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	Hyperfine, Inc. Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-10-24 09:00AM	Hyperfine, Inc. to Expand Global Market Reach with Appointment of International Distributors in Key European Markets (Business Wire)
May-06-24 10:00AM	Will Hyperfine, Inc. (HYPR) Report Negative Earnings Next Week? What You Should Know (Zacks)
Apr-29-24 04:05PM	Hyperfine, Inc. to Announce First Quarter 2024 Financial Results on May 13, 2024 (Business Wire)
Apr-25-24 09:35AM	Down -19% in 4 Weeks, Here's Why Hyperfine (HYPR) Looks Ripe for a Turnaround (Zacks)
Apr-23-24 09:00AM	Hyperfine, Inc. Takes the Stage at ISMRM with Seventeen Abstracts Assessing the Potential of Using Swoop System Images Across Multiple Care Settings and Clinical Conditions (Business Wire)
Apr-17-24 09:00AM	Leading Institutions Enroll First Alzheimers Patients Receiving Amyloid-Targeting Therapy in CARE PMR Study (Business Wire) -8.08%
Mar-21-24 08:53PM	HYPR Stock Earnings: Hyperfine Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace) -10.62%
05:25PM	Hyperfine, Inc. (HYPR) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-12-24 09:00AM	Hyperfine, Inc. Collaborates with Kings College London to Demonstrate the Swoop System and UNITY Project to The Princess Royal (Business Wire) -10.66%
04:30PM	Loading…
Mar-07-24 04:30PM	Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2023 Financial Results on March 21, 2024 (Business Wire)
Feb-28-24 04:30PM	Hyperfine, Inc. to Present at the Oppenheimer 34th Annual Healthcare Conference (Business Wire) +7.77%
Feb-21-24 09:00AM	Hyperfine, Inc. Announces Collaboration with Athletic Heart to Provide Vital Brain Health Imaging for Former Professional Athletes (Business Wire)
Feb-01-24 08:00AM	Hyperfine, Inc. Celebrates Breadth of Swoop System Data Presented at the 2024 International Stroke Conference and Provides an Update on Enrollment in ACTION PMR Stroke Observational Study (Business Wire)
Jan-09-24 09:00AM	Hyperfine, Inc. Launches AI-powered Brain Imaging Software for Enhanced Image Quality and Ease of Use (Business Wire)
Nov-29-23 07:07AM	22nd Century Appoints Larry Firestone as Chairman and CEO (GlobeNewswire)
Nov-20-23 09:00AM	Hyperfine, Inc. Announces Presentations on Clinical Advancements at RSNA 2023 (Business Wire) -5.65%
Nov-16-23 09:00AM	Hyperfine, Inc. to Present at the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-12-23 10:10AM	Hyperfine, Inc. (NASDAQ:HYPR) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	Hyperfine, Inc. Reports Third Quarter 2023 Financial Results (GlobeNewswire) -21.37%
Nov-02-23 09:15AM	Observational Study Finds That Hyperfine, Inc. Portable MR Brain Imaging System Assists Clinicians in Early Detection of Acute Brain Injury in ECMO Patients (Business Wire)
Oct-19-23 04:05PM	Hyperfine, Inc. to Announce Third Quarter Financial Results on November 9, 2023 (Business Wire)
Oct-10-23 04:05PM	Hyperfine, Inc. Announces Promotions of Two Key Clinical Affairs Executives (Business Wire)
Oct-09-23 09:00AM	Hyperfine, Inc. Receives FDA Clearance for Updated AI-powered Software with Improved Image Quality for All Swoop System Sequences (Business Wire)
Sep-07-23 04:05PM	Hyperfine, Inc. to Present at Gilmartin Group Emerging Growth Showcase (Business Wire) -5.10%
Aug-14-23 04:05PM	Hyperfine, Inc. Reports Second Quarter 2023 Financial Results (GlobeNewswire) +7.31%
Aug-09-23 09:00AM	Enrollment Completed for HOPE PMR Pediatric Hydrocephalus Study Using Hyperfine, Inc. Portable MR Imaging® System (Business Wire)
Jul-24-23 04:05PM	Hyperfine, Inc. to Announce Second Quarter Financial Results on August 14, 2023 (Business Wire) -5.46%
Jul-18-23 04:05PM	Hyperfine, Inc. Announces Promotion of Tom Teisseyre, Ph.D. to Chief Operating Officer (Business Wire) +35.47%
Jul-11-23 09:00AM	Hyperfine, Inc. Launches Observational Study to Define New Imaging Paradigm in Stroke Care (Business Wire)
Jun-08-23 09:00AM	Hyperfine, Inc. and the International Society for Magnetic Resonance in Medicine Collaborate to Enhance Global Access to MR Education (Business Wire)
May-18-23 09:00AM	Hyperfine, Inc. Receives Grant for an Additional Three Years to Utilize Innovative Swoop® Portable MR Imaging® System in Low and Middle-Income Countries (Business Wire)
May-11-23 04:05PM	Hyperfine, Inc. Reports First Quarter 2023 Financial Results (GlobeNewswire)
Apr-20-23 04:05PM	Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023 (GlobeNewswire)
Mar-21-23 04:05PM	Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) +10.71% -9.68%
Mar-06-23 08:55AM	Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023 (GlobeNewswire) +23.68%
Feb-28-23 08:55AM	Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging (GlobeNewswire) +15.83%
Feb-21-23 08:55AM	Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations (GlobeNewswire)
Feb-13-23 08:55AM	Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System (GlobeNewswire)
Feb-09-23 04:10PM	Latest Data Demonstrate Potential of the Swoop® Portable MR Imaging® System in the Follow-up of Stroke Patients Who Have Received a Thrombectomy (GlobeNewswire)
Feb-08-23 04:05PM	Hyperfine, Inc. Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer (GlobeNewswire) +8.93%
Feb-06-23 06:31PM	Hyperfine Swoop® Point-of-Care MRI System Takes the Stage at ISMRM with Twelve Abstract Inclusions (GlobeNewswire) -5.08%
Nov-22-22 04:05PM	Hyperfine to Present at the 5th Annual Evercore ISI HealthCONx Conference (GlobeNewswire) -7.97% +9.88%
Nov-10-22 04:05PM	Hyperfine Reports Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-27-22 04:10PM	Hyperfine to Announce Third Quarter 2022 Financial Results on November 10, 2022 (GlobeNewswire)
Oct-06-22 09:00AM	Hyperfine Names Maria Sainz President and Chief Executive Officer (GlobeNewswire) +6.61%
Sep-07-22 08:30AM	BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council (GlobeNewswire)
Aug-24-22 04:10PM	Hyperfine to Participate in Upcoming Investor Conferences (GlobeNewswire) +5.69%
Aug-15-22 06:11AM	Jonathan Rothberg Is The Founder & Vice Chairman of Hyperfine, Inc. (NASDAQ:HYPR) And They Just Picked Up 24% More Shares (Simply Wall St.)
Aug-10-22 04:05PM	Hyperfine Reports Second Quarter 2022 Financial Results (GlobeNewswire) +5.24% -23.23%
Jul-20-22 04:15PM	Hyperfine to Announce Second Quarter 2022 Financial Results on August 10, 2022 (GlobeNewswire) +11.76%
Jul-14-22 09:00AM	Hyperfine Announces Zero Radiation Dose Rapid MR Imaging Test for Pediatric Hydrocephalus Patients (GlobeNewswire) -5.06%
Jun-29-22 04:05PM	Hyperfine Announces CEO Transition (GlobeNewswire) +24.42% -17.41%
Jun-18-22 08:10AM	A Hyperfine, Inc. (NASDAQ:HYPR) insider increased their holdings by 4.3% last year (Simply Wall St.)
08:07AM	Founder & Vice Chairman Jonathan Rothberg Just Bought 4.3% More Shares In Hyperfine, Inc. (NASDAQ:HYPR) (Simply Wall St.)
Jun-14-22 04:10AM	Hyperfine Announces Expansion into Australia and New Zealand with Medical Device Registration and Notification (GlobeNewswire)
May-25-22 04:10PM	Hyperfine to Present at the 2022 Jefferies Global Healthcare Conference (GlobeNewswire) +5.68%
May-11-22 04:05PM	Hyperfine Reports First Quarter 2022 Financial Results (GlobeNewswire) -17.91%
May-03-22 12:15PM	What Percentage Of Hyperfine, Inc. (NASDAQ:HYPR) Shares Do Insiders Own? (Simply Wall St.) +8.76%
10:31AM	Buy These 2 Beaten-Down Stocks Before They Rebound, Says Wells Fargo (TipRanks)
Apr-20-22 04:05PM	Hyperfine to Announce First Quarter 2022 Financial Results on May 11, 2022 (GlobeNewswire) +5.19%
Mar-31-22 06:18PM	Investors in Hyperfine (NASDAQ:HYPR) have unfortunately lost 66% over the last year (Simply Wall St.) +5.37%
Mar-23-22 04:05PM	Hyperfine Reports Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire) -6.23%
Mar-03-22 09:00AM	Hyperfine to Announce Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Mar-01-22 04:10PM	Hyperfine to Present at the 42nd Annual Cowen Healthcare Conference (GlobeNewswire) -10.73%
Feb-16-22 08:00AM	Queens University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities (GlobeNewswire)
Feb-08-22 08:00AM	Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director (GlobeNewswire) +6.80%
Feb-07-22 05:38PM	Monashee Investment Management LLC Buys Vanguard Total Stock Market ETF, Hyperfine Inc, Agree ... (GuruFocus.com) -9.49%
Jan-19-22 08:00AM	M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering (GlobeNewswire) -10.72%
Jan-10-22 07:30AM	Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations (GlobeNewswire)
Jan-04-22 08:30AM	Hyperfine to Present at the 40th Annual J.P. Morgan Healthcare Conference (PR Newswire)

Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
TEISSEYRE THOMAS	Chief Operating Officer	Aug 16 '24	Sale	1.05	2,746	2,883	91,027	Aug 16 05:04 PM
TEISSEYRE THOMAS	Chief Operating Officer	May 16 '24	Sale	0.88	2,753	2,423	93,773	May 16 05:33 PM
TEISSEYRE THOMAS	Chief Operating Officer	Feb 16 '24	Sale	1.11	3,230	3,585	96,526	Feb 16 04:06 PM
TEISSEYRE THOMAS	Chief Operating Officer	Nov 16 '23	Sale	1.26	2,655	3,345	99,756	Nov 17 07:34 PM

Open in Screener

QSI

Quantum-Si Incorporated

Sep 06 • 04:00PM ET

0.9108

Dollar change +0.0046
Percentage change 0.51	%

Healthcare • Medical Devices • USA • NASD

Chart Stock Detail • Compare Perf. • Short Interest • Financials • Options • Save to Portfolio • Create Alert

QSI Quantum-Si Incorporated daily Stock Chart

Held by: ARKG VTI IWM VXF IWN VTWO IWC VTWV RSSL IWV

Index	RUT	P/E	-	EPS (ttm)	-0.63	Insider Own	32.15%	Shs Outstand	121.83M	Perf Week	-6.15%
Market Cap	129.66M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.65%	Shs Float	96.59M	Perf Month	11.07%
Income	-89.35M	PEG	-	EPS next Q	-0.20	Inst Own	31.45%	Short Float	6.06%	Perf Quarter	-41.24%
Sales	1.70M	P/S	76.27	EPS this Y	1.47%	Inst Trans	-1.76%	Short Ratio	7.22	Perf Half Y	-56.42%
Book/sh	1.64	P/B	0.56	EPS next Y	-17.91%	ROA	-29.89%	Short Interest	5.85M	Perf Year	-60.57%
Cash/sh	1.53	P/C	0.59	EPS next 5Y	-	ROE	-32.58%	52W Range	0.73 - 2.46	Perf YTD	-54.69%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-38.30%	52W High	-63.05%	Beta	2.88
Dividend TTM	-	Quick Ratio	20.13	Sales past 5Y	0.00%	Gross Margin	-223.38%	52W Low	24.43%	ATR (14)	0.08
Dividend Ex-Date	-	Current Ratio	20.57	EPS Y/Y TTM	22.49%	Oper. Margin	-5999.65%	RSI (14)	45.07	Volatility	6.56% 9.40%
Employees	165	Debt/Eq	0.01	Sales Y/Y TTM	270.81%	Profit Margin	-5249.65%	Recom	2.00	Target Price	2.75
Option/Short	Yes / Yes	LT Debt/Eq	0.00	EPS Q/Q	9.96%	Payout	-	Rel Volume	0.68	Prev Close	0.91
Sales Surprise	-11.65%	EPS Surprise	13.51%	Sales Q/Q	203.41%	Earnings	Aug 07 AMC	Avg Volume	810.48K	Price	0.91
SMA20	-3.12%	SMA50	-7.15%	SMA200	-39.92%	Trades		Volume	554,294	Change	0.51%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-08-23	Initiated	H.C. Wainwright	Buy	$3
Sep-25-23	Downgrade	Canaccord Genuity	Buy → Hold	$3.50 → $2
Oct-20-21	Initiated	Canaccord Genuity	Buy	$13

Sep-04-24 06:00AM	Liberate Bio Integrates Quantum-Si's Next-Generation Protein Sequencing Platform to Enhance Gene Therapy Development (Business Wire)
Aug-27-24 06:01PM	CORRECTING and REPLACING Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
04:30PM	Quantum-Si Announces New Executive Team Members to Accelerate the Evolution of the Company into a Leading Proteomic Tool Provider (Business Wire)
Aug-26-24 06:00AM	Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire) -5.94%
Aug-07-24 04:02PM	Quantum-Si Reports Second Quarter 2024 Financial Results (Business Wire) -5.91%
04:05PM	Loading…
Jul-30-24 04:05PM	Quantum-Si to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-17-24 04:05PM	Quantum-Si to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire) -6.03%
Jul-09-24 03:56PM	3 Super-Cheap Penny Stocks for the Ultimate Speculator (InvestorPlace)
Jun-10-24 09:00AM	Quantum-Si Announces Presentation on the Use of Next-Generation Protein Sequencing to Detect Disease-Relevant Proteoforms at the Festival of Genomics and Biodata (Business Wire)
May-31-24 08:00AM	Quantum-Si Announces Presentations at ASMS and ESHG (Business Wire)
May-30-24 04:05PM	Quantum-Si Appoints Former Bio-Techne President and CEO, Chuck Kummeth, to serve as independent Chairman of the Board of Directors (Business Wire)
May-09-24 04:01PM	Quantum-Si Reports First Quarter 2024 Financial Results (Business Wire) -7.10%
Apr-30-24 08:30AM	Quantum-Si Announces Upgrades to Analysis Software that will Provide Customers with Higher Data Output and Precision and Shorter Processing Time (Business Wire)
Apr-18-24 04:05PM	Quantum-Si to Report First Quarter 2024 Financial Results on May 9, 2024 (Business Wire)
Mar-21-24 04:05PM	Quantum-Si Appoints Former Illumina and Cisco Systems Executive, Paula Dowdy, to its Board of Directors (Business Wire) -5.79%
12:01PM	Loading…
Mar-07-24 12:01PM	Quantum-Si and Researchers to Highlight the Power of Next-Generation Protein Sequencing on Platinum at US HUPO Conference (Business Wire) +29.81%
Feb-29-24 04:05PM	Quantum-Si Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire) +10.78%
Feb-27-24 08:30AM	Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar (Business Wire) +5.36%
Feb-09-24 08:00AM	Quantum-Si to Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024 (Business Wire) +6.94%
Feb-05-24 08:00AM	Quantum-Si Expands Proteome Coverage and Increases Sequencing Output with New Enhancements to Its Next-Generation Protein Sequencing Platform (Business Wire)
Jan-18-24 08:30AM	Quantum-Si Introduces Worlds First Next-Generation Protein Sequencer in Japan with Addition of New Distributor (Business Wire)
Dec-12-23 08:30AM	Quantum-Si Expands Global Reach with Addition of New Distributor (Business Wire)
Nov-15-23 08:30AM	Quantum-Si Adds Distributor ELTA 90 as Demand for Platinum Grows (Business Wire)
Nov-11-23 09:18AM	Quantum-Si incorporated (NASDAQ:QSI) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 04:05PM	Quantum-Si Reports Third Quarter 2023 Financial Results (Business Wire) +7.26% +6.77%
Nov-08-23 08:15AM	Quantum-Si Honored as Proteomics Company of the Year by the BioTech Breakthrough Awards (Business Wire) -6.06%
Nov-01-23 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Oct-31-23 08:00AM	Quantum-Si Presents its Vision to Transform Genomics and Proteomics Research at ASHG 2023 (Business Wire)
Oct-17-23 08:30AM	Quantum-Si to Report Third Quarter 2023 Financial Results on November 9, 2023 (Business Wire)
Oct-05-23 06:36PM	CORRECTING AND REPLACING Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
08:00AM	Loading…
08:00AM	Quantum-Si Hosts Webinar on Advances in Protein Identification and Characterization (Business Wire)
Oct-03-23 08:00AM	Quantum-Si to Present at The Festival of Genomics & Biodata 2023 in Boston, Massachusetts (Business Wire)
Sep-21-23 08:00AM	Quantum-Si Appoints Biotech Executive and Entrepreneur, Amir Jafri, to its Board of Directors (Business Wire)
Aug-22-23 07:05AM	Quantum-Sis Platinum Next-Generation Protein Sequencing Instrument Wins Honorable Mention in Fast Companys 2023 Innovation by Design Awards (Business Wire)
Aug-16-23 04:00PM	Quantum-Si Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-14-23 06:02PM	Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -9.73%
Aug-07-23 08:00AM	Quantum-Si Reports Second Quarter 2023 Financial Results (Business Wire) -32.15%
Jul-26-23 08:00AM	Quantum-Si to Participate in the Canaccord Genuity 43rd Annual Growth Conference (Business Wire)
Jul-18-23 04:00PM	Quantum-Si to Report Second Quarter 2023 Financial Results on August 7, 2023 (Business Wire) +9.57%
Jun-21-23 08:00AM	Quantum-Si Announces the Appointment of Industry Veteran Johan Denecke as Senior Vice President of Operations (Business Wire)
Jun-07-23 08:00AM	Quantum-Si Debuts New Headquarters in Branford, Connecticut (Business Wire)
May-25-23 08:00AM	Quantum-Si to Participate in the Jefferies Healthcare Conference (Business Wire) -5.99%
May-22-23 08:00AM	Quantum-Si Appoints Life Sciences and Diagnostics Industry Leader Jack Kenny to its Board of Directors (Business Wire) +15.13%
May-15-23 08:00AM	Scott Mendel Elected to Quantum-Si Board of Directors (Business Wire)
May-11-23 04:00PM	Quantum-Si Reports First Quarter 2023 Financial Results (Business Wire) -5.52% -8.44%
May-02-23 08:00AM	Quantum-Si Announces the Appointment of Jeff Keyes as Chief Financial Officer (Business Wire)
Apr-24-23 08:00AM	Quantum-Si Bolsters Executive Leadership Team with Four Key Appointments (Business Wire)
Apr-20-23 08:00AM	Quantum-Si to Report First Quarter 2023 Financial Results on May 11, 2023 (Business Wire)
Apr-14-23 08:00AM	Quantum-Si To Present Poster on Single-Molecule Method for Detection of Arginine Post-Translational Modifications at the AACR Annual Meeting 2023 (Business Wire)
Mar-24-23 08:00AM	Quantum-Si to Participate in B. Riley Securities' Life Sciences Tools Conference - Proteomics Setting the Blueprint for Innovative Drug Creation, Virtual Conference (Business Wire)
Mar-06-23 08:00AM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2022 Financial Results (Business Wire) -12.96%
Feb-17-23 08:00AM	Quantum-Si to Participate in the 43rd Annual Cowen Health Care Conference (Business Wire)
Feb-13-23 04:00PM	Quantum-Si to Report Fourth Quarter and Full Year 2022 Financial Results on March 6, 2023 (Business Wire)
Jan-09-23 08:00AM	Quantum-Si Begins Commercial Shipments of the PlatinumTM Protein Sequencing System and Provides Business Updates at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire) +8.72%
08:00AM	Quantum-Si and Biovista Partner to Provide AI-Driven Deep Proteomics Insights from the Platinum Next-Generation Protein Sequence Platform Output (Business Wire)
08:00AM	Quantum-Si and Aviva Systems Biology Partner to Co-Develop Sample Preparation Kits for Protein Sequencing (Business Wire)
Dec-22-22 04:05PM	Quantum-Si to Participate in the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-20-22 08:00AM	Quantum-Si Announces Commercial Availability of PlatinumTM, the Worlds First Next-Generation Single-Molecule Protein Sequencing Platform (Business Wire)
Dec-08-22 08:00AM	Quantum-Si Joins Human Proteome Organization (HUPO) Industrial Advisory Board (Business Wire)
Nov-07-22 04:05PM	Quantum-Si Reports Third Quarter 2022 Financial Results (Business Wire)
Nov-03-22 04:00PM	Quantum-Si to Participate in the 16th Annual Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (Business Wire) -11.15%
Oct-17-22 04:05PM	Quantum-Si to Report Third Quarter 2022 Financial Results on November 7, 2022 (Business Wire) +6.11%
Oct-13-22 02:00PM	Quantum-Sis Next-Generation Single-Molecule Protein Sequencing Technology Published in Science, Signaling New Era of Life Science and Biomedical Research (Business Wire)
Oct-04-22 08:00AM	Quantum-Si Appoints Jeff Hawkins as Chief Executive Officer (Business Wire) +18.48%
Aug-26-22 08:00AM	Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Business Wire) -6.40%
Aug-08-22 04:02PM	Quantum-Si Reports Second Quarter 2022 Financial Results (Business Wire) -9.34%
Jul-29-22 08:30AM	Quantum-Si to Participate at Two Upcoming Investor Conferences (Business Wire)
Jul-18-22 04:42PM	Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022 (Business Wire) +7.91%
Jun-22-22 08:45AM	Quantum-Si Set to Join the Russell 2000® Index (Business Wire) +6.83%
Jun-16-22 04:30PM	Quantum-Si Appoints Vikram Bajaj, Ph.D., to Board of Directors (Business Wire) -10.71%
Jun-01-22 08:45AM	Quantum-Si Highlights Technology Advancements at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire)
May-25-22 08:00AM	Quantum-Si to Present at the 2022 Jefferies Healthcare Conference (Business Wire)
May-17-22 11:00AM	Quantum-Si to Present Research and Development Updates at the VIB Next-Generation Protein Analysis and Detection Conference (Business Wire) +8.09%
May-10-22 08:00AM	Quantum-Si to Present at the 2022 UBS Global Healthcare Conference (Business Wire)
May-09-22 04:05PM	Quantum-Si Reports First Quarter 2022 Financial Results (Business Wire) -11.87%
04:01PM	Quantum-Si Appoints Patrick Schneider as President and Chief Operating Officer (Business Wire)
Apr-18-22 04:13PM	Quantum-Si to Report First Quarter 2022 Financial Results on May 9, 2022 (Business Wire)
Mar-28-22 04:05PM	Quantum-Si to Present at the B. Riley Securities Disruptive Biotech Enabling Technologies Virtual Mini Conference (Business Wire) +13.91%
Mar-14-22 12:39PM	What You Need To Know About Quantum-Si incorporated's (NASDAQ:QSI) Investor Composition (Simply Wall St.) -5.85%
Feb-28-22 04:05PM	Quantum-Si Reports Fourth Quarter and Fiscal Year 2021 Financial Results (Business Wire) -5.88% +13.46%
Feb-18-22 09:21AM	Quantum-Si to Present at the 42nd Annual Cowen Health Care Conference (Business Wire) +11.65%
Feb-14-22 04:05PM	Quantum-Si Announces Dr. Jonathan Rothberg as Interim CEO (Business Wire) -6.24%
Feb-07-22 04:05PM	Quantum-Si to Report Fourth Quarter and Full Year 2021 Financial Results on February 28, 2022 (Business Wire)
Jan-10-22 04:10PM	Quantum-Si Provides Business Updates at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) -9.15% +7.51%
Jan-04-22 08:00AM	Quantum-Si Signs Lease for New Headquarters in New Haven (Business Wire) -6.57%
Dec-21-21 08:00AM	Quantum-Si to Present at the 40th Annual J.P. Morgan Healthcare Conference (Business Wire) +22.91%
Dec-14-21 09:25AM	Quantum-Si Added to the Nasdaq Biotechnology Index (Business Wire)
Dec-02-21 10:15AM	3D Systems Names Claudia Napal Drayton to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Quantum-Si Reports Third Quarter 2021 Financial Results (Business Wire)
Nov-09-21 08:00AM	Quantum-Si Acquires Majelac Technologies to Strengthen Chip Supply Chain (Business Wire)
Nov-04-21 04:05PM	Quantum-Si to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum (Business Wire)
Oct-19-21 04:15PM	Quantum-Si Announces Expansion of Early Access Program for the Platinum Single Molecule Protein Sequencing Platform (Business Wire)
Sep-21-21 04:15PM	Quantum-Si Incorporated to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference (Business Wire) +8.03%
Sep-13-21 11:26AM	What Type Of Shareholders Make Up Quantum-Si incorporated's (NASDAQ:QSI) Share Registry? (Simply Wall St.)
Aug-16-21 04:05PM	Quantum-Si Reports Second Quarter 2021 Financial Results (Business Wire)
Aug-11-21 07:00AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 16, 2021 (Business Wire) -5.78%
Jul-27-21 08:30AM	Quantum-Si to Report Second Quarter 2021 Financial Results on August 12, 2021 (Business Wire) -8.78%
Jun-24-21 04:05PM	Quantum-Si Signs Lease for Product Development and Operations Facility in San Diego Biotechnology Hub (Business Wire)

Quantum-Si, Inc. engages in the development of a proprietary universal single-molecule detection platform to enable Next-Generation Protein Sequencing, the ability to sequence proteins in a massively parallel fashion. It can be used for the study of nucleic acids. Its platform includes Carbon automated sample preparation instrument, Platinum NGPS instrument, Quantum-Si Cloud software service, and reagent kits and chips for use with its instruments. The company was founded by Jonathan M. Rothberg on June 24, 2013 and is headquartered in Branford, CT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hawkins Jeffrey Alan	President & CEO	Aug 09 '24	Buy	0.85	25,000	21,272	1,003,757	Aug 13 06:01 AM
LaPointe Christian	General Counsel & Corp. Secr.	Aug 09 '24	Buy	0.86	25,000	21,610	571,710	Aug 13 06:01 AM
Keyes Jeffry R.	Chief Financial Officer	Aug 09 '24	Buy	0.87	50,000	43,465	446,820	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 09 '24	Buy	0.87	138,900	120,926	323,900	Aug 13 06:01 AM
Kummeth Charles R.	Director	Aug 12 '24	Buy	0.89	31,100	27,533	355,000	Aug 13 06:01 AM
Johnston Grace	Chief Commercial Officer	Jun 21 '24	Sale	1.21	4,359	5,262	299,109	Jun 25 07:18 PM
Johnston Grace	Chief Commercial Officer	Jun 24 '24	Sale	1.20	3,169	3,790	295,940	Jun 25 07:18 PM
Hawkins Jeffrey Alan	President & CEO	Mar 14 '24	Buy	1.76	25,000	44,000	25,000	Mar 18 08:21 AM
LaPointe Christian	General Counsel & Corp. Secr.	Mar 15 '24	Buy	1.74	10,000	17,400	257,693	Mar 18 08:07 AM
Keyes Jeffry R.	Chief Financial Officer	Mar 05 '24	Buy	1.61	50,000	80,500	50,000	Mar 06 05:09 PM

HYPR

Hyperfine Inc

QSI

Quantum-Si Incorporated

Upgrade your FINVIZ experience